Kelly Financial Services’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12
| Closed | -$174 | – | 490 |
|
|
2024
Q2 | $174 | Hold |
12
| – | – | ﹤0.01% | 744 |
|
|
2024
Q1 | $186 | Hold |
12
| – | – | ﹤0.01% | 740 |
|
|
2023
Q4 | $336 | Hold |
12
| – | – | ﹤0.01% | 722 |
|
|
2023
Q3 | $571 | Hold |
12
| – | – | ﹤0.01% | 670 |
|
|
2023
Q2 | $1.15K | Hold |
12
| – | – | ﹤0.01% | 591 |
|
|
2023
Q1 | $1.36K | Hold |
12
| – | – | ﹤0.01% | 560 |
|
|
2022
Q4 | $1.34K | Hold |
12
| – | – | ﹤0.01% | 538 |
|
|
2022
Q3 | $1.54K | Hold |
12
| – | – | ﹤0.01% | 537 |
|
|
2022
Q2 | $823 | Hold |
12
| – | – | ﹤0.01% | 573 |
|
|
2022
Q1 | $1.71K | Hold |
12
| – | – | ﹤0.01% | 530 |
|
|
2021
Q4 | $2K | Hold |
12
| – | – | ﹤0.01% | 536 |
|
|
2021
Q3 | $1.67K | Sell |
12
-274
| -96% | -$38.1K | ﹤0.01% | 532 |
|
|
2021
Q2 | $240K | Buy |
286
+274
| +2,283% | +$230K | 0.01% | 279 |
|
|
2021
Q1 | $4.94K | Hold |
12
| – | – | ﹤0.01% | 399 |
|
|
2020
Q4 | $5.88K | Buy |
12
+7
| +140% | +$3.43K | ﹤0.01% | 350 |
|
|
2020
Q3 | $2.83K | Hold |
5
| – | – | ﹤0.01% | 399 |
|
|
2020
Q2 | $476 | Buy |
+5
| New | +$476 | ﹤0.01% | 532 |
|